pubmed-article:2158829 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2158829 | lifeskim:mentions | umls-concept:C0010823 | lld:lifeskim |
pubmed-article:2158829 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:2158829 | lifeskim:mentions | umls-concept:C0005961 | lld:lifeskim |
pubmed-article:2158829 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:2158829 | pubmed:dateCreated | 1990-6-1 | lld:pubmed |
pubmed-article:2158829 | pubmed:abstractText | We report the incidence of cytomegalovirus (CMV) seroconversion, infections and mortality in 169 consecutive thalassemic patients transplanted in Pesaro. We observed a 44% incidence of early seroconversion and a 52% incidence of late seroconversion. No relationship was found between seroconversion and acute or chronic graft-versus-host disease (GVHD) or rejection. The donor status did not influence the incidence of seroconversion, GVHD and rejection. Only three patients died of CMV infection (1.7%); in each case CMV disease was the final cause of death in patients with severe acute GVHD. | lld:pubmed |
pubmed-article:2158829 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2158829 | pubmed:language | eng | lld:pubmed |
pubmed-article:2158829 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2158829 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2158829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2158829 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2158829 | pubmed:month | Mar | lld:pubmed |
pubmed-article:2158829 | pubmed:issn | 0268-3369 | lld:pubmed |
pubmed-article:2158829 | pubmed:author | pubmed-author:LucarelliGG | lld:pubmed |
pubmed-article:2158829 | pubmed:author | pubmed-author:PolchiPP | lld:pubmed |
pubmed-article:2158829 | pubmed:author | pubmed-author:BaroncianiDD | lld:pubmed |
pubmed-article:2158829 | pubmed:author | pubmed-author:GalimbertiMM | lld:pubmed |
pubmed-article:2158829 | pubmed:author | pubmed-author:AngelucciEE | lld:pubmed |
pubmed-article:2158829 | pubmed:author | pubmed-author:DurazziS MSM | lld:pubmed |
pubmed-article:2158829 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2158829 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:2158829 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2158829 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2158829 | pubmed:pagination | 167-72 | lld:pubmed |
pubmed-article:2158829 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:meshHeading | pubmed-meshheading:2158829-... | lld:pubmed |
pubmed-article:2158829 | pubmed:year | 1990 | lld:pubmed |
pubmed-article:2158829 | pubmed:articleTitle | Cytomegalovirus infections in thalassemic patients after bone marrow transplantation. | lld:pubmed |
pubmed-article:2158829 | pubmed:affiliation | Divisione ematologica e Centro trapianto di midollo osseo di Muraglia, Ospedale di Pesaro, Italy. | lld:pubmed |
pubmed-article:2158829 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2158829 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |